CSL, ResMed, Primary Health Care [ + ]

Researchers from Australia and the US find that blood cells are derived from a number of stem cell subtypes. [ + ]

The sight of brown seaweed is not one that would normally have people seeing dollar signs, but for Hobart-based Marinova, its solvent-free technique for extracting the coveted element fucoidan from an introduced species of sea-flora in Tasmania has made it one of Australia’s most promising up and coming biotechs. [ + ]

The regulation of in vitro diagnostics in Australia will undergo significant change as pre-market regulatory approval and inclusion on the Australian Register of Therapeutic Goods is required for IVD devices under the new regulatory scheme, which comes into force on 1 July 2010.

Applications open today for over $150,000 in prizes and fellowships. [ + ]

$20 million state-of-the-art manufacturing facility acquired for $3.85 million. [ + ]

Final results of phase Ia trial of BNC210 announced demonstrating safety and efficacy. [ + ]

Preliminary results look good in clinical pharmacokinetic study comparing SUBA-Itraconazole with Sporanox. [ + ]

A better understanding of neuropeptide Y could lead to new therapeutics to treat obesity. Herbert Herzog gives some insights in to this complex system. [ + ]

Solagran and BioProspect to develop commercialisation plan for animal health and nutrition products. [ + ]

A discovery by Monash University scientists could see humble cotton thread emerge as a core material in low-cost ‘lab-on-chip’ devices capable of detecting diseases such as kidney failure and diabetes.

$102 million in NHMRC grants target epilepsy, malaria, melanoma, pain, infant health, medical tests, infection, aging, Indigenous health and stuttering. [ + ]

Issued patent for lead product PAT-CM1 provides protection through the year 2023. [ + ]

UPDATED: Release of OvPlex ovarian cancer test in UK sends shares soaring. [ + ]

New research shows the microRNA, miR-9, plays a significant role in metastasis and blood vessel growth in breast cancer and could provide a target for future therapies. [ + ]